CDH1 and breast carcinoma: Our in vivo study suggests that in this model, E-cadherin is a major phenotypic driver for metastatic colonization and is lost in EMT sites of the primary tumor, and this was supported by the poorer survival seen in grade III breast cancers expressing high levels of E-cadherin mRNA.